Does the Effectiveness of a Medicine Copay Voucher Vary by Baseline Medication Out‐Of‐Pocket Expenses? Insights From ARTEMIS

BACKGROUND: Persistence to P2Y12 inhibitors after myocardial infarction (MI) remains low. Out‐of‐pocket cost is cited as a factor affecting medication compliance. We examined whether a copayment intervention affected 1‐year persistence to P2Y12 inhibitors and clinical outcomes. METHODS AND RESULTS:...

Descripción completa

Detalles Bibliográficos
Autores principales: Rymer, Jennifer A., Kaltenbach, Lisa A., Peterson, Eric D., Cohen, David J., Fonarow, Gregg C., Choudhry, Niteesh K., Henry, Timothy D., Cannon, Christopher P., Wang, Tracy Y.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9673662/
https://www.ncbi.nlm.nih.gov/pubmed/36250667
http://dx.doi.org/10.1161/JAHA.122.026421

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9673662/
https://www.ncbi.nlm.nih.gov/pubmed/36250667
http://dx.doi.org/10.1161/JAHA.122.026421

Ejemplares similares